Skip to main content
SpringerLink
Log in

Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure

  • Originals
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

We examined the effects of 60 minα-hANP infusion (24 ng/min/kg) on glomerular filtration rate (GFR), renal blood flow (RBF), cardiac index (CI) and blood pressure (BP) in 8 patients with chronic renal failure (CRF) with GFR ranging from 18 to 80 ml/min/1.73 m2 and in 8 control (C) subjects with normal renal function. Basal plasma levels of ANP and cGMP were elevated in CRF (ANP: 60.6±9.1 vs 13.6±1.9 pmol/l,p<0.05; cGMP: 14.3±2.9 vs 6.6±1.1 pmol/ml,p<0.05). During ANP infusion, peak levels of cGMP were higher in CRF than in C (27.5±3.2 vs. 17.3±1.3 pmol/ml,p<0.05). During ANP infusion, GFR increased in CRF by 70.7±4.2% from 34.5±6.8 to 57.4±9.9 ml/min/1.73m2 (p<0.001) as compared to 16.2±1.4% in C (p<0.001 vs CRF). RBF increased in CRF by 43.6±6.4% and in C by 3.1±1.2% (p<0.01). Basal urinary sodium excretion (UNaV) was slightly lower in CRF than in C but rose to the same level in both groups during ANP infusion. In CRF, as opposed to C, UNaV remained elevated above baseline after the end of the infusion. The effect of ANP on fractional sodium excretion (FENa), however, was more pronounced in C. Basal FENa was higher in CRF (12.8±2.5% vs 2.4±1.5% in C,p<0.001), FENa remained elevated at 180% over baseline in C sixty minutes after cessation of ANP infusion, while it had returned to baseline in CRF. During ANP infusion, CI increased in CRF after 30 min from 2.91±0.08 to 3.12±0.091/min/m2 (p<0.001) and in C from 3.20±0.11 to 3.39±0.13 l/min/m2 (p< 0.05). Mean arterial BP was higher in CRF and its decrease was greater than in C (21.1±2.7% vs 9.1±1.0%,p<0.001). In patients with CRF GFR, RPF, and CI remained significantly elevated and BP was still significantly decreased 60 min after ANP infusion. Total peripheral vascular resistance (TPR) was elevated in CRF and declined during ANP infusion in both CRF and C. The decline of TPR was sustained and more pronounced in CRF than in C. Renal vascular resistance (RVR) was high in CRF and dropped by nearly 50% during ANP infusion, whereas only a moderate decline in RVR during ANP application was observed in C. Thus, exogenous ANP had greater and prolonged effects on systemic hemodynamics and renal function in CRF than in C. They may be due to higher levels of ANP following ANP infusion and appear to be mediated by a more sustained formation of the second messenger cGMP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ANP:

atrial natriuretic peptide

CRF:

chronic renal failure;

GFR:

glomerular filtration rate

FF:

filtration fraction

ERPF:

effective renal plasma flow

ERBF:

effective renal blood flow

BP:

blood pressure

MAP:

mean arterial blood pressure

HR:

heart rate

SV:

stroke volume

CO:

cardiac output

CI:

cardiac index

TPR:

total peripheral resistance

RVR:

renal vascular resistance

UNaV:

urinary sodium excretion

FENa :

fractional sodium excretion

PRA:

plasma renin activity

ECFV:

extracellular fluid volume

PAH:

paminohippuric acid

References

  1. Borenstein HB, Cupples WA, Sonnenberg H, Veress AT (1983) The effect of natriuretic atrial extract on renal hemodynamics and urinary excretion in anesthetized rats. J Physiol [Lond] 334:133–140

    Google Scholar 

  2. Burnier M, Mooser V, Wauters JP, Marder HK, De Vane P, Nussberger J, Waeber B, Brunner HR (1989) Bolus injection of synthetic atrial natriuretic peptide in patients with chronic renal failure or nephrotic syndrome. J Cardiovasc Pharmacol 13:682–690

    Google Scholar 

  3. Canella G, Rodella A, Brunori G, Gaggiotti M, Sandrini M, Maiorca R (1987) Plasma concentrations of atrial natriuretic peptide in relation to body fluid status in chronic uremia. Nephrol Dial Transplant 2:158–160

    Google Scholar 

  4. Cody RJ, Atlas SA, Laragh JH (1986) Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal and hemodynamic responses to peptide infusion. J Clin Invest 78:1362–1374

    Google Scholar 

  5. Czekalski S, Michel C, Dussaule JC, Touraine P, Mignon F, Ardaillou R (1988) Atrial natriuretic peptide and adaptation of sodium urinary excretion in patients with chronic renal failure. Clin Sci 75:243–249

    Google Scholar 

  6. Earle DP, Berliner RW (1946) A simplified clinical procedure for measurement of glomerular filtration rate and renal plasma flow. Proc Soc Exp Biol Med 62:262–266

    Google Scholar 

  7. Epstein M (1989) Atrial natriuretic factor in patients with liver disease. Am J Nephrol 9:89–100

    Google Scholar 

  8. Epstein M, Norsk P, Loutzenhiser R (1989) Effects of water immersion on atrial natriuretic peptide release in humans. Am J Nephrol 9:1–24

    Google Scholar 

  9. Espiner EA, Nicholls MG, Yandle TG (1986) Studies on the secretion, metabolism and action of atrial natriuretic peptide in man. J Hypertens 4 (Suppl 2):S85-S91

    Google Scholar 

  10. Gerbes AL, Arendt RM, Paumgartner G (1987) Atrial natriuretic factor. Possible implications in liver disease. J Hepatol 5:123–132

    Google Scholar 

  11. Gerbes AL, Kollenda MC, Vollmar AM, Reichen J, Vakil N, Scarborough RM (1991) Altered density of glomerular binding sites for atrial natriuretic factor in bile duct-ligated rats with ascites. Hepatol 13:562–566

    Google Scholar 

  12. Gerbes AL, Vollmar AM (1990) Degradation and clearance of atrial natriuretic factors (ANF). Life Sci 47:1173–1180

    Google Scholar 

  13. Glänzer K, Prüßing B, Kramer HJ (1982) Hemodynamic and hormonal responses to 8-Arginine-Vasopressin in healthy man: effects of indomethacin. Klin Wochenschr 60:1234–1239

    Google Scholar 

  14. Haller BGD, Züst HJ, Shaw S, Gnädinger MP, Uehlinger DE, Weidmann P (1987) Effects of posture and aging on circulating atrial natriuretic peptide levels in man. J Hypertens 5:551–556

    Google Scholar 

  15. Hammond TG, Yusufi ANK, Knox FG, Dousa TP (1985) Administration of atrial natriuretic factor inhibits proximal Na-coupled solute transport. J Clin Invest 75:1983–1989

    Google Scholar 

  16. Harris PJ, Thomas D, Morgan TO (1987) Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption. Nature (London) 326:697–698

    Google Scholar 

  17. Hollister AS, Tanaka I, Imada T (1986) Sodium loading and posture modulate human atrial natriuretic factor plasma levels. Hypertension 8 (Suppl II):II-106–II-111

    Google Scholar 

  18. Katsube N, Schwartz D, Needleman P (1985) Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressure. Biochem Biophys Res Commun 133:937–944

    Google Scholar 

  19. Kollenda MC, Vollmar AM, McEnroe GA, Gerbes AL (1990) Dehydration increases the density of C receptors for ANF in rat glomerular membranes. Am J Physiol 258:R1084-R1088

    Google Scholar 

  20. Lang RE, Tholken H, Ganten D, Luft FC, Ruskoaho H, Unger T (1985) Atrial natriuretic factor: A circulating hormone stimulated by volume loading. Nature (London) 314:264–266

    Google Scholar 

  21. Maack TM, Kleinert HD (1986) Renal and cardiovascular effects of atrial natriuretic factor. Biochem Pharmacol 35:2057–2064

    Google Scholar 

  22. Meyer-Lehnert H, Till C, Predel HG, Kramer HJ (1989) Beeinflußt Nifedipin die Sekretion von atrialem natriuretischem Peptid während Wasserimmersion? In: Kaufmann W, Wambach M (Eds) Endocrinology of the heart. Springer, Berlin, p 236–239

    Google Scholar 

  23. Michel H, Meyer-Lehnert H, Bäcker A, Stelkens H, Kramer HJ (1990) Regulation of atrial natriuretic peptide receptors in glomeruli during chronic salt loading. Kidney Int 38:73–79

    Google Scholar 

  24. Nakao K, Sugawara A, Morii N (1986) The pharmacokinetics of a-human atrial natriuretic polypeptide in healthy subjects. Eur J Clin Pharmacol 31:101–103

    Google Scholar 

  25. Nakaoka H, Imataka K, Amano M, Fuji J, Ishibashi M, Yamaji T (1985) Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 313:1027–1036

    Google Scholar 

  26. Nishiuchi T, Saito H, Yamasaki Y, Shiro S (1986) Radioimmunoassay for atrial natriuretic peptide: method and results in normal subjects and patients with various diseases. Clin Chim Acta 159:45–57

    Google Scholar 

  27. Ogawa K, Smith AI, Hodsman GP, Jackson B, Woodcock EA, Johnston CI (1987) Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure. Clin Exp Pharmacol Physiol 14:95–102

    Google Scholar 

  28. Ortola FV, Ballermann B, Brenner BM (1988) Endogenous ANP augments fractional excretion of Pi, Ca, and Na in rats with reduced renal mass. Am J Physiol 255:F1091-F1097

    Google Scholar 

  29. Predel HG, Kipnowski J, Meyer-Lehnert H, Kramer HJ (1988) Human atrial natriuretic peptide in non-dialyzed patients with chronic renal failure. Clin Nephrol 31:150–151

    Google Scholar 

  30. Predel HG, Schulte-Vels O, Sorger M, Glänzer K, Geller C, Kramer HJ (1990) Atrial natriuretic peptide in patients with diabetes mellitus type I. Effects on systemic and renal hemodynamics and renal excretory function. Am J Hyperten 3:674–681

    Google Scholar 

  31. Proctor KG, Bealer SL (1986) Selective antagonism of hormone-induced vasoconstriction by atrial natriuretic factor in the rat microcirculation. Circ Res 61:42–49

    Google Scholar 

  32. Rascher W, Tulassay T, Lang RE (1985) Atrial natriuretic peptide in plasma of volume overloaded children with chronic renal failure. Lancet 2:303–305

    Google Scholar 

  33. Richards AM, Nicholls MG, Ikram H (1985) Renal hemodynamic and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers. Lancet II:545–549

    Google Scholar 

  34. Richards AM, Tonolo G, Montrosi P, Finlayson J, Fraser R, Inglis G, Towrie A, Morton JJ (1988) Low dose infusion of 26- and 28-amino acid human atrial natriuretic peptides in normal man. J Clin Endocrin Metab 66:465–472

    Google Scholar 

  35. Saxenhofer H, Gnädinger MP, Weidmann P, Shaw S, Schohn D, Hess C, Uehlinger DE, Jahn H (1987) Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int 32:554–561

    Google Scholar 

  36. Schmidt RW, Bourgoignie JJ, Bricker NS (1966) On the adaptation in sodium excretion in chronic uremia. The effects of “proportional reduction” of sodium intake. J Clin Invest 53:1736–1741

    Google Scholar 

  37. Slatopolski E, Elkan IO, Weerts C, Bricker NS (1968) Studies on the characteristics of the control system governing sodium excretion in uremic man. J Clin Invest 47:521–530

    Google Scholar 

  38. Solomon LR, Atherton JC, Bobinski H, Hillier V, Green R (1988) Effect of low dose infusion of atrial natriuretic peptide on renal function in man. Clin Sci 75:403–410

    Google Scholar 

  39. Sonnenberg H, Honrath U, Chong CK, Wilson DR (1986) Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 250:F963-F966

    Google Scholar 

  40. Steiner AL, Parker CW, Kipnis DM (1972) Radioimmunoassay for cyclic nucleotides. J Biol Chem 247:1106–1110

    Google Scholar 

  41. Suda S, Weidmann P, Saxenhofer H, Cottier C, Shaw SG, Ferner C (1988) Atrial natriuretic factor in mild to moderate chronic renal failure. Hypertension 11:483–490

    Google Scholar 

  42. Tonolo G, McMillan M, Polonia J, Pazzola A, Montorsi P, Soro A, Glorioso N, Richards MA (1988) Plasma clearance and effects ofα-hANP infused in patients with end-stage renal failure. Am J Physiol 254:F895-F899

    Google Scholar 

  43. Vetter W, Vetter H, Siegenthaler W (1973) Radioimmunoassay for aldosterone without chromatography: 2. Determination of plasma aldosterone. Acta Enocrinol 74:558–567

    Google Scholar 

  44. Walker RG, Swainson CP, Yandle TG, Nicholls MG, Espiner EA (1987) Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure. Clin Sci 72:19–24

    Google Scholar 

  45. Weidmann P, Hellmüller B, Uehlinger DE (1986) Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man. J Clin Endocrinol Metab 62:1027–1036

    Google Scholar 

  46. Yamaji T, Ishibashi M, Takaku F (1985) Atrial natriuretic factor in human blood. J Clin Invest 76:1705–1709

    Google Scholar 

  47. Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, Livesey JH (1986) Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sci 38:1827–1833

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Universitäts-Poliklinik Bonn, Deutschland

    H. Meyer-Lehnert, T. Bayer, H. -G. Predel, K. Glänzer & H. J. Kramer

Authors
  1. H. Meyer-Lehnert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Bayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. -G. Predel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Glänzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. J. Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dedicated to Prof. Dr. med. F. Krück on the occasion of his 70th birthday

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meyer-Lehnert, H., Bayer, T., Predel, H.G. et al. Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure. Klin Wochenschr 69, 895–903 (1991). https://doi.org/10.1007/BF01649565

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01649565

Key words

Search

Navigation